No Data
No Data
Analysts Conflicted on These Healthcare Names: Galmed Pharmaceuticals (GLMD) and Regeneron (REGN)
Top Midday Gainers
Crude Oil Down 2%; Roper Technologies Increases 2025 Outlook
Dow Jumps Over 150 Points; Domino's Pizza Posts Upbeat Earnings
Galmed Signed Term Sheet for the Development of Novel Semaglutide Sublingual Formulation
Galmed Pharmaceuticals Enters Sponsored Project Agreement With Virginia Commonwealth University To Evaluate Aramchol's Effect On Overcoming Drug Resistance In Gastrointestinal Cancers